BioStem Technologies Inc.
BSEM | NASDAQ
$1.12
-$0.17 (-13.18%)
At close: Oct 30, 2026, 4:00 PM ET
$1.38
+$0.26 (+23.21%)
Pre-market:
Nov 2, 2026, 4:15 AM ET
-13.18%
(1D)No price chart data available for 1D timeframe.
Rating
38
+3.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #576/1028 (Top 56%)
Key Statistics
Market Data
Market Cap $20.91M
1D Range
1.11 1.29
52W Range
1.11 8.20
Valuation (TTM)
PE -0.67
PB 0.76
EV/EBITDA -0.69
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $7.00
Cash Flow
FCF Yield -42.2%
SBC Adj. FCF Yield -61.0%
SBC Impact -44.3%
Margins
Gross Margin 113.9%
Operating Margin 38.7%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -76.0% |
21.6%
Dil EPS 3Y | 5Y -1200.0% |
-31.1%
FCF 3Y | 5Y -91.8% |
27.4%
Returns
ROA -58.0%
ROE -76.1%
ROIC -80.9%
Financial Health
Net Cash
$5.74M
Current Ratio 0.98
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
BioStem Technologies, Inc. engages in the development, manufacturing, and commercialization of placental-derived allografts for advanced wound care and regenerative therapies in the United States. It ...
Sector Healthcare
Industry Biotechnology
Employees 73
IPO Date Mar 17, 2015
Website biostemtechnologies.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove BSEM